Alaaeldin Abdelmajid Basheer Abdelmajid - Infectious Diseases

Author Information

Alaaeldin Abdelmajid Basheer Abdelmajid is affiliated with the Communicable Diseases Center and the Division of Infectious Diseases, Department of Medicine at Hamad Medical Corporation in Doha, Qatar. His work is primarily focused on infectious diseases, with a particular emphasis on the management and treatment of COVID-19 and its complications.

Research Contributions

Alaaeldin Abdelmajid Basheer Abdelmajid has contributed significantly to the field of infectious diseases, with a particular focus on COVID-19. His research includes the use of antiviral treatments such as Remdesivir and Favipiravir for COVID-19 patients, especially those with chronic conditions like kidney disease. Additionally, his work has explored the psychological impacts of the pandemic on individuals in institutional quarantine settings. His research also extends to rare case studies such as SARS-CoV-2 presenting as colitis and cytomegalovirus reactivation leading to myocardial infarction in an immunocompetent individual.

Aliases

Alaaeldin Abdelmajid Basheer Abdelmajid is known by several aliases including Alaaeldin Abdelmajid, Alaaeldin A Abdelmajid, and A. Abdelmajid.

Publication and Citation Metrics

Metric	Value
Total Papers	13
Total Citations	54
h-index	4

Publications:

Remdesivir for Covid-19 pneumonia in patients with severe chronic kidney disease: Case series and review of the literature

DOI: 10.22541/au.164120188.85772322/v1

Year: 2022

Remdesivir for COVID‐19 pneumonia in patients with severe chronic kidney disease: A Case series and review of the literature

DOI: 10.1002/ccr3.5467

Year: 2022

Psychological impact of the COVID-19 pandemic within institutional quarantine and isolation centres and its sociodemographic correlates in Qatar: a cross-sectional study

DOI: 10.1136/bmjopen-2020-045794

Year: 2021

Remdesivir therapy causing bradycardia in COVID-19 patients: Two case reports

DOI: 10.1016/j.idcr.2021.e01254

Year: 2021

508. Title Favipiravir for the Treatment of Coronavirus Disease 2019; A Propensity Score Matched Cohort Study

DOI: 10.1093/ofid/ofab466.707

Year: 2021

SARS-CoV-2 infection presenting as colitis with chest and abdomen CT findings

DOI: 10.1016/j.radcr.2020.09.035

Year: 2020

Reactivation cytomegalovirus leading to acute myocardial infarction- a first reported case in an immunocompetent patient

DOI: 10.22541/au.160672684.48090644/v1

Year: 2020

What is Community Hygiene and its Importance?

What are the Treatment Options for Strep Throat?

What Is the Relationship Between Climate Change and Food Security?

What are HIV Antivirals?

What are the future prospects of Dengvaxia?

What Are the Challenges in Genomic Studies of Infectious Diseases?

What is the Global Impact of Hepatitis B?

How is HIV diagnosed?

How Can Individuals and Communities Help in WHO’s Efforts?

What are the Advantages of HTS in Infectious Disease Research?

Partnered Content Networks

Relevant Topics